Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
An overview of index funds with the lowest fees for retirement in 2024, highlighting how fees affect long-term returns and what to consider.
27,284 articlesInvestors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Oklo faced a sharp pullback in early 2026 as sector bets cooled and financing moves pressured shares. This guide brea...
PennantPark Investment’s hefty yield hinges on a reserve that funds part of its payouts and a portfolio heavy in floa...
Suncor Energy has climbed sharply this year, but is the rally justified for new buyers? This guide breaks down the dr...
A single headline about 500 million barrels can spark fear or opportunity in oil investing. This article unpacks what...
Ron Paul challenges President Trump’s move to hold government stakes in private companies, arguing it threatens liber...
Markets react as reports surface that the u.s.-iran deal nears, paired with warnings from a Trump ally about Tehran’s...
Energy income investors face a critical test as crude prices swing. This report examines the dividend safety check: e...
Hot IPOs and rapid meme stocks grab headlines, but durable income and resilience win long games. Here are three stock...
June brings a wave of AI-focused optimism to fintech stocks. Nu Holdings shines as AI-powered lending gains attention...
Lawmakers are weighing a tax bill that could reshape crypto mining, staking, and other digital-asset activities. This...
UBS analysts warn that aging housing stock could spark a repair-driven upcycle for major home-improvement retailers. ...